Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifevantage (LFVN) Shares Outstanding (Diluted Average) (2016 - 2025)

Lifevantage's Shares Outstanding (Diluted Average) history spans 16 years, with the latest figure at $12.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 3.28% year-over-year to $12.7 million; the TTM value through Dec 2025 reached $12.7 million, down 3.28%, while the annual FY2025 figure was $13.0 million, 0.01% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $12.7 million in Q4 2025 per LFVN's latest filing, down from $12.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $14.3 million in Q2 2021 to a low of $12.5 million in Q3 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $13.1 million, with a median of $13.0 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): dropped 8.4% in 2022, then grew 4.91% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $13.3 million in 2021, then fell by 5.59% to $12.5 million in 2022, then increased by 0.55% to $12.6 million in 2023, then increased by 4.48% to $13.2 million in 2024, then fell by 3.28% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFVN's Shares Outstanding (Diluted Average) are $12.7 million (Q4 2025), $12.9 million (Q3 2025), and $13.0 million (Q2 2025).